Evidence map›Paper›PMID 36220945›Full record

ArticleJournal of general internal medicine2023

Prevalence of Substance Use Disorders in Sickle Cell Disease Compared to Other Chronic Conditions: a Population-Based Study of Black American Adults.

Charles R Jonassaint, Julia O'Brien, Emily Nardo, Robert Feldman, Michael Stanton, Laura DeCastro, Kaleab Z Abebe

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Charles R JonassaintCenter for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA. cjonassaint@pitt.edu.ORCID 0000-0002-5662-5806
Julia O'BrienSchool of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Emily NardoCenter for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA.
Robert FeldmanCenter for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA.
Michael StantonHealth Sciences, California State University, East Bay, Hayward, CA, USA.
Laura DeCastroSection of Benign Hematology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Kaleab Z AbebeCenter for Research on Health Care, University of Pittsburgh, Pittsburgh, PA, USA.
University of Pittsburgh · USCalifornia State University, East Bay · US

Funding

Technology Research in Chronic & Critical IllnessT32NR008857 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Young Ji Lee · 2005 to 2026
$4.0M
Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment for Adolescents and Adults with Sickle Cell DiseaseR34MH125152 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JONASSAINT, CHARLES RICHARD · 2020 to 2021
$706k
NIMH NIH HHS R34 MH125152NINR NIH HHS T32 NR008857
6 · The paper itself

Abstract

backgroundSickle cell disease (SCD) is a heritable chronic health condition characterized by pain symptoms throughout the life course that are routinely treated with opioids.

objectiveThis study examined differences in substance use disorders in Black American adults with SCD compared to those with other chronic conditions or with no chronic conditions.

designData from a population-representative sample of Black Americans with SCD, other chronic conditions, and no chronic conditions were obtained from the National Survey of American Life (NSAL) database. Diagnosis of substance use disorder was determined by structured clinical interview. Hierarchical models controlling for covariates (demographics, socioeconomic status, self-rated health, and mood disorders) compared odds of diagnosis between the three groups.

participantsThe sample included 4238 African-American and Black Caribbean participants from the NSAL study who were 18 years of age or older. MAIN MEASURES: Measures included age, sex, income, education, marital status, employment, possession of health insurance, health conditions, and substance use disorders diagnosed by structured clinical interview. KEY

resultsControlling for age, sex, and socioeconomic status, there were no differences in odds of a drug use disorder when comparing individuals with SCD to Black adults with other chronic conditions (OR = 1.12; p = 0.804) or no chronic condition (OR = 2.09; p = 0.102). SCD was, however, associated with greater odds of alcohol use disorders when compared to the groups with other chronic conditions (OR = 2.15; p = 0.01) and no chronic conditions (OR = 5.11; p < 0.001). This effect was not better accounted for by socioeconomic status, marital status, self-rated physical health, or the presence of a mood disorder.

conclusionsSCD was not a risk factor for drug use disorders. Further data will be needed to understand the factors contributing to increased risk of alcohol use disorders in SCD and the role uncontrolled pain symptoms may have in driving substance use.

Indexed as

AlcoholismAnemia, Sickle CellSubstance-Related DisordersAdultBlack or African AmericanChronic DiseaseHumansPainPrevalenceUnited Statesalcohol use disorderchronic diseasedrug use disordersickle cellsubstance use disorder

Identifiers

PMID36220945
PMCPMC10110804
OpenAlexW4304203145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.